Novavax Stock Surges as FDA Lifts Clinical Hold on Its COVID-19 and Flu Vaccine
Novavax Stock Surges Novavax Stock Surges has lifted its clinical hold on Novavax’s late-stage trial for its COVID-19 and influenza combination vaccine, as well as its standalone flu vaccine. Novavax (NASDAQ: NVAX) announced the news on Monday, resulting in a 13% increase in the company’s stock in premarket trading. Initial Hold Due to Participant’s Health …
Novavax Stock Surges as FDA Lifts Clinical Hold on Its COVID-19 and Flu Vaccine Read More »